Of note, elevated CD73 expression does not appear to be due to genomic alterations in the CD73 gene; mutations, chromosomal copy-number changes, and rearrangements in CD73 are uncommon in glioblastoma (<0.5%) and other tumor types (Fig. S4a). This evidence concerns the gene NT5E and neoplasm.